Skip to main content
Amgen8-K: Governance change

Amgen appoints Thomas Dittrich as new CFO effective Sept 1, 2026, replacing retiring Peter Griffith.

What happened

Mr. Dittrich's experience leading a 'company-wide transformation program' at his prior company suggests a high probability of new initiatives and budget re-evaluation at Amgen.

Source

SEC EDGARMay 19, 2026

Current report (Form 8-K)

Amgen 8-K

Filing excerpt

On May 19, 2026, Amgen Inc. (the “Company”) publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026.

sec.gov/Archives/edgar/data/318154/000031815426000097/amgn-20260519.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Governance change

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
05/19
Filed
May 19, 2026

The full record

From the Signal API record

Numbers

Dollar figure
$14.8M (Total one-time cash, RSU, retention, and relocation bonuses (in CHF) to hire new CFO Thomas Dittrich.)
PercentNew CFO's target bonus opportunity as a percentage of annual base salary.
1%

Details

CIK
318154
Accession number
0000318154-26-000097
Timeframe
Next quarter
Filing year
2026
Why it matters
Governance tools needed
Signal category
Esg

Topics and mentions

Technologies

  • IT

Competitors

  • Takeda Pharmaceutical Company

Regions named

  • Switzerland
  • California

Extraction

Confidence
High
Relevance
100%
Sentiment
Neutral
Detected
May 26, 2026
signal_type
sec-8k
signal_subtype
governanceChange

Use this data

Get every 8-K signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/d19a3e6a-039f-4787-bed2-bfc3716d3f47 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "d19a3e6a-039f-4787-bed2-bfc3716d3f47",
  "signal_type": "sec-8k",
  "signal_subtype": "governanceChange",
  "detected_at": "2026-05-26T10:04:43.229+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "A new CFO often triggers a 90-day review of financial systems, vendor contracts, and strategic priorities. Mr. Dittrich's experience leading a 'company-wide transformation program' at his prior company suggests a high probability of new initiatives and budget re-evaluation at Amgen.",
    "metrics": {
      "pct": 1,
      "timeframe": "next_quarter",
      "pct_context": "New CFO's target bonus opportunity as a percentage of annual base salary.",
      "dollar_context": "Total one-time cash, RSU, retention, and relocation bonuses (in CHF) to hire new CFO Thomas Dittrich.",
      "dollar_millions": 14.75
    },
    "summary": "Amgen appoints Thomas Dittrich as new CFO effective Sept 1, 2026, replacing retiring Peter Griffith.",
    "excerpts": "On May 19, 2026, Amgen Inc. (the “Company”) publicly announced that Peter H. Griffith will retire from the role of the Company’s Executive Vice President and Chief Financial Officer, effective August 31, 2026.",
    "relevance": 1,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000097/amgn-20260519.htm",
    "filing_date": "2026-05-19",
    "filing_year": 2026,
    "fiscal_year_end": "05/19",
    "sales_relevance": "Governance tools needed",
    "signal_category": "esg",
    "regions_mentioned": [
      "Switzerland",
      "California"
    ],
    "competitors_mentioned": [
      "Takeda Pharmaceutical Company"
    ],
    "technologies_mentioned": [
      "IT"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.